Hearts in space: a Belgian story of successful collaboration

Article

Belgium needs boldness for healthcare innovation

This year, Science for health will explore the inspiring innovations at the interface of biology and technology. The event will […] September 27, 2023 · BioVox

Article

Lean years for company creation in Europe?

After an exceptional sequence of socio-economic shocks over the past few years, the number of new companies being formed in […] September 27, 2023 · V-Bio Ventures

Article

Pharmaceutical market access: how real-world data fuel better health beyond clinical trials

Studies of a drug’s effectiveness and safety don’t end with clinical trials – they extend beyond market access when the […] September 27, 2023 · Janssen Pharmaceutica

News

V-Bio Ventures portfolio company Orionis Biosciences announces collaboration with Genentech to discover and develop molecular glue class medicines

September 20, 2023, BOSTON, MA and GHENT, Belgium – Orionis Biosciences, a privately held life sciences company with an integrated […] September 20, 2023 · V-Bio Ventures

News

Augustine Therapeutics expands its leadership team and R&D platform, enters regulatory development.

Leuven, Belgium, September 12th, 2023 – Augustine Therapeutics, a biotech company developing innovative therapies for neuromuscular and neurodegenerative disorders, announced […] September 12, 2023 · Quality by Design - Business & Communications

News

V-Bio Ventures portfolio company Corteria Pharmaceuticals raises EUR 65 million to advance its transformational medicines for cardiovascular diseases

Ghent, Belgium, 7 September 2023 – Corteria Pharmaceuticals, a V-Bio Ventures portfolio company, is a biopharmaceutical company specialized in the […] September 7, 2023 · V-Bio Ventures

Article

Jan Rabaey on the convergence of biology and technology

Belgian Prof. Jan Rabaey has spent the past 35 years conducting pioneering tech research at the University of California at […] August 23, 2023 · BioVox